Results 161 to 170 of about 58,831 (274)

Clinical trial of safety and antitumor activity of farletuzumab ecteribulin in patients with platinum‐resistant ovarian cancer: Phase I expansion results

International Journal of Gynecology &Obstetrics, Volume 173, Issue 3, Page 1334-1342, June 2026.
Abstract Objective In the dose‐escalation part of Study 101, which included multiple tumor types, objective responses were observed in 10 of 22 patients across multiple dose levels of farletuzumab ecteribulin (FZEC). We explored the safety/antitumor activity of FZEC in patients with platinum‐resistant ovarian cancer (PROC) from the Study 101 expansion ...
Kan Yonemori, Mayu Yunokawa, Koji Matsumoto, Kazuhiro Takehara, Kosei Hasegawa, Yasuyuki Hirashima, Hidenori Kato, Hiroki Ikezawa, Yohei Otake, Wataru Yusa, Takuma Miura, Shin Nishio   +11 more
wiley   +1 more source

Case Report: Clinical course and extended survival in a canine patient with pericardial mesothelioma managed without chemotherapeutic intervention. [PDF]

Front Vet Sci
Park SG, Lim S, Moon J, I-Se O, Chung T, Kim D.   +5 more
europepmc   +1 more source

Diagnostic yield and safety of probe-based confocal laser endomicroscopy-guided pleural biopsy via semirigid thoracoscope in diagnosing patients with unknown pleural effusion: a protocol for a multicentre, randomised controlled trial (COLLABORATION-I). [PDF]

BMJ Open
Deng MM, Hu Y, Liu X, Feng Y, Zheng Z, Tong R, Porcel J, Hou G.   +7 more
europepmc   +1 more source

Mosunetuzumab Successfully Treated Rituximab‐Refractory Lymphoma‐Associated Protein‐Losing Enteropathy With Concomitant Immune Thrombocytopenia in Follicular Lymphoma: A Case Report

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Protein‐losing enteropathy (PLE) is a rare but potentially severe complication of malignant lymphoma characterized by excessive gastrointestinal loss of plasma proteins, leading to hypoalbuminemia, edema, and serous effusions. We report a case of follicular lymphoma complicated by severe PLE and concomitant immune thrombocytopenia (ITP ...
Takashi Matsunaga, Naohi Sahara, Mai Mizusawa, Yukiko Miura, Seiichiro Kobayashi, Tomoki Fujii, Nobuhiro Oono   +6 more
wiley   +1 more source

The application of probe-based confocal laser endomicroscopy in pleural diseases. [PDF]

Medicine (Baltimore)
Yuan M, Luo B, Song C, Hu Y, Qian Q, Ye S.   +5 more
europepmc   +1 more source

Palliation of malignant pleural effusion

, 2018
Maligni plevralni izliv je pogost spremljevalec maligne bolezni. Pri bolnikih najpogosteje povzroča dispnejo, kašelj in bolečino v prsnem košu. Cilji paliativnega zdravljenja so: lajšanje simptomov, izboljšanje bolnikove zmogljivosti in kakovosti ...
Rozman, Aleš
core  

British Thoracic Society Quality Standard for Pleural Disease. [PDF]

BMJ Open Respir Res
Roberts ME, Rahman NM, Addala DN, Bedawi E, Bhatnagar M, Denniston P, Elsheikh A, Hassan M, Halliday R, Hallifax R, Iqbal B, McCracken D, Opstad KS, Roberts HJ, Stanton AE.   +14 more
europepmc   +1 more source

No Time to Bleed! Ultrasound-Guided Management of a Pleural Biopsy Complication: A Case Report. [PDF]

Respirol Case Rep
Piamonti D, Stirpe F, Calabrò N, Carriero E, Romaniello D, Sglavo R, Giarnieri E, Carico E, Pignatelli P, Bonini M, Ricci A.   +10 more
europepmc   +1 more source

First Case of Acute Pleural Empyema Caused by Mediterraneibacter gnavus

Respirology Case Reports, Volume 14, Issue 6, June 2026.
We report the first case of acute pleural empyema caused by Mediterraneibacter gnavus, a gut commensal organism, identified by anaerobic culture in combination with MALDI‐TOF mass spectrometry and 16S rRNA gene sequencing. This case suggests that M. gnavus can act as an opportunistic pathogen in patients with significant comorbidities and highlights ...
Masahiro Shirata, Michiko Tsuchiya
wiley   +1 more source

Diagnostic Utility of Pleural Fluid Lactate and Pleural Fluid-to-Serum Lactate Ratio in Differentiating Various Etiologies of Exudative Pleural Effusions: A Cross-Sectional Observational Study. [PDF]

Cureus
Ambedare S, Bharti P, Garg S, Debnath E, Kumar A, Yadav VP, Ambedare T.   +6 more
europepmc   +1 more source